Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease

No abstract available.

Information

Citation

Naylor KL, McArthur E, Dixon SN, Kwong JC, Thomas D, Balamchi S, Blake PG, Garg AX, Atiqazaaman M, Hladunewich MA, Levin A, Yeung A, Oliver MJ. Kidney Int. 2023; 103(4):791-7. Epub 2023 Jan 30.

View Source

Contributing ICES Scientists

Research Programs

Kidney, Dialysis & Transplantation

Associated Topics

Associated Sites

ICES Western

Discover More

Journal Article

03/10/2024

Neurological events following COVID-19 vaccination: does ethnicity matter?

Vyas MV, Chen R, Campitelli MA, Odugbemi T, Sharpe I, Chu JY. Can J Neurol Sci. Epub 2024 Oct 3.

Journal Article

01/10/2024

SARS-CoV-2, Tdap, and influenza vaccination during pregnancy from 2019 to 2022 in Ontario, Canada: a population-based retrospective cohort study

Greyson D, Correia R, Howard M, Darling EK, Kirkwood D, Davis A, Mniszak C, Jones A, Molinaro M, Vanstone M. CMAJ. 2024; 196(32)E1100-E1113.

Journal Article

27/09/2024

What happened to the patients? Care trajectories for persons with a delayed hospital discharge during wave 1 of COVID-19 in Ontario, Canada; a population-based retrospective cohort study

Guilcher SJT, Bai YQ, Wodchis WP, Bronskill SE, Rashidian L, Kuluski K. PLoS One. 2024; 19(9):e0309155.

See All